Within the scope of our investigation, we explored signalling pathways that regulate MGMT expression in melanoma cells and found that TMZ stimulation promoted p‐ERK1/2 protein expression and increased MGMT promoter transcriptional activity. The gene discussed is MAPK3; the disease is melanoma.